CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy
SHENZHEN, CHINA, Aug 26, 2022 – (ACN Newswire) – China Medical System Holdings Limited (“CMS”,…
Year: 2022
Leading tech professionals to virtually discuss cloud solutions and sustainable data centres in Qatar
QATAR, UAE, Sept 3, 2022 – (ACN Newswire) – The potential of the cloud and…
Turquoise Hill Enters into Definitive Agreements with Rio Tinto
MONTREAL–(BUSINESS WIRE)–Turquoise Hill Resources Ltd. (“Turquoise Hill” or the “Company”) (TSX: TRQ) (NYSE: TRQ) announced…
Clover’s COVID-19 Vaccine Candidate Demonstrates Superior Booster Responses Compared to Inactivated Vaccine
— Up to 12-fold higher neutralizing antibody titers observed in participants who received SCB-2019 (CpG…
Governor Newsom’s AB 257 Stamp of Approval Will Hurt California Consumers, Workers and Small Businesses
Newsom Signs Into Law Reckless Bill that Will Increase Costs 20% For CA’s Restaurant Goers…
Emergent Cold LatAm announces the expansion of the facility located in Palin, confirming its leadership in Guatemala
One more step in Emergent Cold LatAm’s consolidation in a key Central American market. PALIN,…
VALNEVA – Declaration of shares and voting rights: August 31, 2022
VALNEVA Declaration of shares and voting rights August 31, 2022__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6…
Orion Corporation: Acquisition of Own Shares 05.09.2022
Orion Corporation NOTIFICATION 05.09.2022 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 05.09.2022 Date 05.09.2022…
Oobit Registers Legal Entity in Italy Amidst Global Expansion Push
Singapore, Singapore–(Newsfile Corp. – September 5, 2022) – Oobit Technologies Pte. Ltd or “the Company”,…
Dammam Valley/KSA to acquire the majority of Arcensus GmbH/Germany to accelerate the global implementation of Whole Genome Sequencing in genetic diagnostics and delivery of breakthrough technologies in genomic bioinformatics
ROSTOCK, Germany & DAMMAM, KSA, Sep 5, 2022 – (ACN Newswire) – Dammam Valley in…
LanzaTech NZ, Inc., to Participate in Upcoming Investor Conferences
CHICAGO–(BUSINESS WIRE)–LanzaTech NZ, Inc. (“LanzaTech”), an innovative Carbon Capture and Transformation (“CCT”) company that transforms…
Telent announces new Chairman
Warwick, U.K., September 5th 2022 – Telent Ltd, a leading UK technology and network services…
Biotimize Announces the Opening of a Fundraising Round to Build the First Biological CDMO in Brazil
PIRACICABA, Brazil, Sept. 05, 2022 (GLOBE NEWSWIRE) — Biotimize, a functional growth-stage biotechnology as a…
Apexigen Announces New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Neoadjuvant Chemoradiation in Patients with Resectable Esophageal and Gastroesophageal Junction Cancers at ESMO Congress 2022
SAN CARLOS, Calif., Sept. 05, 2022 (GLOBE NEWSWIRE) — Apexigen, Inc. (NASDAQ: APGN) a clinical-stage…
Synthetic Biologics Announces Presentation at ESMO Congress 2022 Describing Phase 1 Investigator-sponsored Study Evaluating VCN-01 in Combination with Durvalumab in Patients with Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and Neck
-Treatment with VCN-01 in combination with durvalumab demonstrated an acceptable safety profile and encouraging biological…
Reef’s Highly Anticipated Reef Card is Officially Available for Crypto Holders
● The Card is officially available for people in the UK and EEA and will…
Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in APAC
SYDNEY, Sep 5, 2022 – (ACN Newswire) – Novotech, the leading Asia Pacific biotech specialist…
Iskratel and S&T Slovenija merge to form S&T Iskratel
Kranj, Slovenia – 5 September 2022 – Customers of leading European ICT company Iskratel will…
Alvotech Reports Update on Initial AVT02 Biologics License Application
REYKJAVIK, Iceland, Sept. 05, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company…
Alvotech Reports Update on Initial AVT02 Biologics License Application
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar…